Sentence examples for binding as previously reported from inspiring English sources

We reasoned that the positive Δ F could be a result of positive allostery resulting in enhanced binding, as previously reported in the literature.

The previously characterized A1 receptor agonist ABEA-X-BY630 (2) had a similar apparent log KD value to NECA (Table 2: Figure 3), but displaced only 50% of the specific binding as previously reported (Middleton et al., 2007).

Laminin-binding activity was examined as previously reported (20) with slight modifications.

A standard anatomical region-of-interest (ROI) template (constructed according to a stereotactic atlas) and including regions for the caudate nucleus, putamen, whole striatum, midbrain, and occipital cortex (representing non-specific binding) was placed bilaterally on the images, as previously reported [24].

The difference between the K d of [125I]-AB-MECA obtained from our kinetic binding approach and the binding data as previously reported in the literature with traditional saturation binding assays on membranes from human A3R-transfected HEK-293 cells [29] was proved to be statistically not significant (P > 0.05) using two-tailed, unpaired Student's t test with Welch's correction (Fig. 6d).

The K d of [125I]-AB-MECA obtained from the novel kinetic real-time cell-binding studies and from traditional binding assays, as previously reported in the literature (see Table 2 for detailed summary of K d values), was compared using two-tailed, unpaired Student's t test with Welch's correction (d).

It is thus likely that Ste11 regulates the majority of pheromone-regulated genes, perhaps in some cases via co-operative binding to a number of relatively weak binding sites as previously reported [ 14].

The binding affinity of the lipopeptides for purified LPS was examined using our synthetic dansyl-polymyxin binding assay as previously reported.

The ratio of hEGR/ actin from densitometry was compared with the tumour EGFR level obtained by ligand binding assay as previously reported for this panel of tumours, with EGFR positive tumours defined by EGF binding of >10 fmol mg−1 protein (Mellon et al, 1996).

Inhibitory constants of the A3R antagonists MRS1191, MRS1523 and FE@SUPPY, respectively, were obtained from competitive real-time cell-binding studies at ambient temperature with 0.7 nM [125I]-AB-MECA on CHO-K1-hA3R cells (group A) and compared to the corresponding K i values obtained from traditional binding assays, as previously reported in the literature (group B).

Following treatment, splenocytes from the mice were isolated and assayed to ensure that PCI-32765 was binding Btk as previously reported [ 17].